Drug Profile
Research programme: N-type calcium channel antagonists - Traxion Therapeutics
Alternative Names: TXT-0200Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Traxion Therapeutics
- Class Small molecules
- Mechanism of Action N type calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neuropathic-pain in USA (PO)
- 18 Sep 2008 Preclinical trials in Neuropathic pain in USA (PO)